To ascertain whether aforementioned PMN cells found in tumor exudates in were possible candidates for anti-PD-1 therapy effector cells, we first determined whether they were lymphocytes (a priori, the immunotherapy target cells). This evidence concerns the gene PDCD1 and neoplasm.